Effect of recombinant canine distemper vaccine on antibody titers in previously vaccinated dogs.
Vet Ther
; 7(2): 107-12, 2006.
Article
em En
| MEDLINE
| ID: mdl-16871492
ABSTRACT
Two canine distemper virus (CDV) vaccine types are currently commercially available modified-live virus (MLV) vaccines and a canarypox recombinant CDV (rCDV) vaccine (Recombitek, Merial). This study compared the ability of the rCDV vaccine and MLV vaccines to significantly enhance (boost) the antibody response of previously immunized adult and juvenile dogs. A significant (fourfold or greater) increase in titer occurred in significantly more dogs revaccinated with Recombitek C-4 or Recombitek C-6 than with the MLV-CDV vaccines. This study demonstrates that Recombitek, the only vaccine for dogs containing rCDV, is more likely to significantly boost the CDV antibody response in previously vaccinated dogs than are the MLV-CDV vaccines. Because rCDV vaccine can boost the antibody titer of dogs previously vaccinated with an MLV vaccine, it can and should be used when core vaccines are readministered.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinas Virais
/
Imunização Secundária
/
Cinomose
/
Vírus da Cinomose Canina
/
Doenças do Cão
/
Anticorpos Antivirais
Limite:
Animals
Idioma:
En
Revista:
Vet Ther
Assunto da revista:
MEDICINA VETERINARIA
/
TERAPEUTICA
Ano de publicação:
2006
Tipo de documento:
Article
País de afiliação:
Estados Unidos